Search results
Royal Bank of Canada Reiterates Outperform Rating for Okta (NASDAQ:OKTA)
ETF DAILY NEWS· 7 hours agoOkta (NASDAQ:OKTA – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at Royal Bank of Canada in a research report issued on Monday, Benzinga reports. Royal ...
Moderna price target raised at Oppenheimer after RSV vaccine approval By Investing.com
Investing.com· 5 days agoModerna price target raised at Oppenheimer after RSV vaccine approval
Vanguard Group Inc. Buys 298,824 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
ETF DAILY NEWS· 5 hours agoVanguard Group Inc. grew its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 1.4% in the 4th quarter, according to its most recent filing with the Securities and ...
Barnes Group shares target raised by Oppenheimer on valuation outlook By Investing.com
Investing.com· 3 days agoOn Friday, Oppenheimer adjusted its outlook on Barnes Group (NYSE:B) shares, a global provider of...
Oppenheimer Reiterates “Outperform” Rating for Adobe (NASDAQ:ADBE)
ETF DAILY NEWS· 3 days agoAdobe (NASDAQ:ADBE – Get Free Report)‘s stock had its “outperform” rating reiterated by equities research analysts at Oppenheimer in a report released on Friday, Benzinga ...
Vanguard Group Inc. Trims Stock Position in Citigroup Inc. (NYSE:C)
ETF DAILY NEWS· 5 hours agoVanguard Group Inc. cut its stake in shares of Citigroup Inc. (NYSE:C – Free Report) by 0.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC ...
The Cigna Group (NYSE:CI) Shares Purchased by Trust Co. of Vermont
ETF DAILY NEWS· 6 hours agoTrust Co. of Vermont lifted its holdings in The Cigna Group (NYSE:CI – Free Report) by 3.1% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 16,886 shares ...
Oppenheimer & Co. Inc. Cuts Stake in Planet Fitness, Inc. (NYSE:PLNT)
ETF DAILY NEWS· 6 days agoOppenheimer & Co. Inc. decreased its stake in Planet Fitness, Inc. (NYSE:PLNT – Free Report) by 6.8% in the 4th quarter, according to its most recent Form 13F filing with ...
Oppenheimer Increases Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $58.00
ETF DAILY NEWS· 7 days agoTandem Diabetes Care (NASDAQ:TNDM – Free Report) had its price objective increased by Oppenheimer from $47.00 to $58.00 in a research note issued to investors on Monday morning ...
Cytokinetics (NASDAQ:CYTK) Given Buy Rating at HC Wainwright
ETF DAILY NEWS· 5 hours agoCytokinetics (NASDAQ:CYTK – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a research report issued on Monday, Benzinga reports. HC ...